Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Alvogen
Alvogen
Activities:
Regulatory
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
Alvogen partners with Kinaxis on supply chain management
Kinaxis will help Alvogen effectively manage its product introduction and tender processes to determine project feasibility and impact across the supply chain
Distribution
Dipharma and Alvogen launch Diterin in South Korea
First drug commercially available for the treatment of hyperphenylalaninemia due to phenylketonuria
Finance
CVC Capital Partners leads consortium to acquire controlling stake in Alvogen
Consortium will provide funds to help Alvogen become a leading generics player worldwide
Finance
Alvogen acquires Dream Pharma of Korea for US$187m
Third significant acquisition for the company in the Asia-Pacific region since 2012
Manufacturing
Alvotech invests US$250m in biopharmaceuticals
Portfolio of biosimilar products to be marketed by sister company, Alvogen
Ingredients
Alvogen expands its operations in India
Clinical service and API sourcing capabilities established
Subscribe now